A Quality-of-Life-Oriented Endpoint for Comparing Therapies
From MaRDI portal
Publication:3201574
DOI10.2307/2531683zbMATH Open0715.62262OpenAlexW2040308389WikidataQ52521595 ScholiaQ52521595MaRDI QIDQ3201574FDOQ3201574
Richard D. Gelber, Rebecca S. Gelman, Aron Goldhirsch
Publication date: 1989
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.2307/2531683
product-limit estimatorKaplan-Meier estimatorquality of lifecancer therapycomparison of therapiesinduced dependencyquantile distance functions
Cited In (31)
- Revisit Kaplan-Meier estimator in estimating QAL survival distributions
- Locally Efficient Estimation of the Quality‐Adjusted Lifetime Distribution with Right‐Censored Data and Covariates
- Quality-Adjusted Survival Estimation with Periodic Observations: A Multistate Survival Analysis Approach
- Some geometric methods for constructing decision criteria based on two-dimensional parame\-ters
- A comparison of some confidence intervals for the mean quality-adjusted lifetime with censored data
- Analysis of quality-of-life adjusted failure time data in the presence of competing, possibly informative, censoring mechanisms
- Nonparametric estimator for the survival function of quality adjusted lifetime (QAL) in a three-state illness-death model
- Estimation of the mean quality-adjusted survival using a multistate model for the sojourn times
- Simultaneous analysis of quality of life and survival data
- Joint Inference for Competing Risks Data Using Multiple Endpoints
- Bayesian analysis of quality adjusted lifetime (QAL) data
- Regression Models for the Mean of the Quality‐of‐Life‐Adjusted Restricted Survival Time Using Pseudo‐Observations
- Testing Equality of Survival Functions of Quality-Adjusted Lifetime
- Multistate models as a framework for estimand specification in clinical trials of complex processes
- Empirical likelihood inference for the regression model of mean quality‐adjusted lifetime with censored data
- Estimating the mean of a mark variable under right censoring on the basis of a state function
- A note on non-identifiability of mark survival function
- Parametric Estimation of Quality Adjusted Lifetime (QAL) Distribution in Simple Illness-Death Model
- Bayesian regression models for the quality adjusted lifetime data with zero time duration health states
- Survival Analysis in Clinical Trials: Past Developments and Future Directions
- Nonparametric Two‐Sample Tests of the Marginal Mark Distribution with Censored Marks
- Efficient Estimation of the Distribution of Quality‐Adjusted Survival Time
- On induced dependent censoring for quality adjusted lifetime (QAL) data in a simple illness-death model
- Quality-Adjusted Survival Estimation with Periodic Observations
- Nonparametric estimation of quality adjusted lifetime distribution in a simple illness-death model
- A semi-Markov multistate model for estimation of the mean quality-adjusted survival for non-progressive processes
- The Two‐Sample Problem with Induced Dependent Censorship
- Semiparametric Bayesian Markov analysis of personalized benefit-risk assessment
- Testing transition probability matrix of a multi-state model with censored data
- Joint Regression Analysis of Survival and Quality-Adjusted Survival
- Nonparametric Estimation of the Bivariate Recurrence Time Distribution
This page was built for publication: A Quality-of-Life-Oriented Endpoint for Comparing Therapies
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q3201574)